Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

NCT00795730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Healthy Subjects

Interventions

DRUG: NSA-789
OTHER: placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer